Research

Hormonal

Subcutaneous recombinant leptin administration induces a dose-dependent reduction in body weight and fat mass in both lean and obese adults, with the majority of weight loss attributable to fat loss.

Daily subcutaneous injections of recombinant leptin can lead to significant fat loss in both lean and obese adults, with higher doses producing greater weight reduction. While the treatment is effective, it requires daily injections and may cause local skin reactions, though these are typically manageable.

GoodSupportsHIGH confidence
A dose-response relationship with weight and fat loss was observed with subcutaneous recombinant leptin injections in both lean and obese subjects... more than 95% of weight loss was fat loss in the 2 highest dose cohorts at 24 weeks.
Steven B. Heymsfield et al. · JAMA · 1999

Why this rating

Randomized, double-blind, placebo-controlled trial with dose escalation, though limited by short duration and high dropout in high-dose groups.

Source

Recombinant Leptin for Weight Loss in Obese and Lean Adults

Steven B. Heymsfield et al. · JAMA · 1999

DOI 10.1001/jama.282.16.1568

rct · n=127Cited 1,425×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →